The Duchenne/Becker muscular dystrophy carrier screening includes the evaluation of mutations in DMD gene and the most widely used analysis is the MLPA for the DMD deletions/duplications detection. The high frequency of de novo mutations permits to estimate a risk up to 20% of mosaicisms for mothers of sporadic DMD children. The purpose of this study is to evaluate alternative analytical strategy for the detection of mosaics carrier women, in order to improve the recurrence risk estimation.
Identification of Duchenne/Becker muscular dystrophy mosaic carriers through a combined DNA/RNA analysis
Arcangeli, Mauro;
2018-01-01
Abstract
The Duchenne/Becker muscular dystrophy carrier screening includes the evaluation of mutations in DMD gene and the most widely used analysis is the MLPA for the DMD deletions/duplications detection. The high frequency of de novo mutations permits to estimate a risk up to 20% of mosaicisms for mothers of sporadic DMD children. The purpose of this study is to evaluate alternative analytical strategy for the detection of mosaics carrier women, in order to improve the recurrence risk estimation.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
